Candid Therapeutics, a pioneering biotechnology firm dedicated to developing innovative therapeutics that materially improve the lives of patients, has announced a monumental funding achievement of $370 million. This substantial investment reflects the confidence that investors place in Candid's mission to transform healthcare for those in need. The funds will be harnessed to accelerate the development of several promising drug candidates, particularly in the areas of chronic disease management and rare genetic disorders, where unmet medical needs persist. Candid is committed to transparency and openness in its goals, plans, and progress, ensuring that stakeholders remain informed about its advancements and milestones. This funding round will also support the expansion of their research and development capabilities, allowing Candid to leverage cutting-edge technologies and methodologies in their therapeutic approaches. As the company embarks on this next phase of innovation, Candid Therapeutics is poised to change the landscape of treatment options available to patients, creating hope and improving quality of life for individuals facing significant health challenges. With a robust pipeline and a steadfast dedication to improving patient outcomes, Candid Therapeutics is ready to make a lasting impact, and this significant funding marks a pivotal step along that journey.
Breaking News: Candid Therapeutics Secures $370 Million Funding to Accelerate Innovative Therapeutics Development
Recently funded 路 $370.0MBiotechnology Research
Get the full Candid Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
